Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
Public ClinicalTrials.gov record NCT01885260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of ISIS 449884 Administered Once Weekly to Patients With Type 2 Diabetes Mellitus Being Treated With Metformin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety and tolerability of ISIS-GCGRRx in combination with metformin versus placebo + metformin
Study identification
- NCT ID
- NCT01885260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 77 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2013 (Type not available)
- Primary completion
- May 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- Jul 4, 2016
2013 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Isis Investigational Site | Birmingham | Alabama | 35216 | — |
| Isis Investigational Site | Muscle Shoals | Alabama | 35662 | — |
| Isis Investigational Site | Anaheim | California | 92801 | — |
| Isis Investigational Site | Chino | California | 91710 | — |
| Isis Investigational Site | Los Angeles | California | 90057 | — |
| Isis Investigational Site | DeLand | Florida | 32720 | — |
| Isis Investigational Site | Fort Lauderdale | Florida | 33306 | — |
| Isis Investigational Site | Miami | Florida | 33143 | — |
| Isis Investigational Site | Marietta | Georgia | 30066 | — |
| Isis Investigational Site | Las Vegas | Nevada | 89101 | — |
| Isis Investigational Site | Cincinnati | Ohio | 45245 | — |
| Isis Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Isis Investigational Site | Eugene | Oregon | 97404 | — |
| Isis Investigational Site | Corpus Christi | Texas | 78404 | — |
| Isis Investigational Site | Katy | Texas | 77450 | — |
| Isis Investigational Site | Salt Lake City | Utah | 84107 | — |
| Isis Investigational Site | Renton | Washington | 98057 | — |
| Isis Investigational Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01885260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 4, 2016 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01885260 live on ClinicalTrials.gov.